Skip to main content

Table 4 Univariate analysis of overall survival

From: The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival

 

HR

95 % CI

P value

Age (y)

1.01

0.98–1.05

.556

Neoadjuvant Therapy

1.08

0.43–2.68

.870

CA 19–9 (kU/mL)

1.38

0.83–2.29

.215

Major Vascular Resection

2.66

0.85–8.30

.093

R1 Resection

1.96

0.84–4.53

.118

Positive Lymph Node Ratio

55.8

4.35–714

.002*

Poor Tumor Differentiation

2.28

0.99–5.23

.053

Tumor Size (cm)

1.06

0.89–1.28

.506

  1. Clinicopathologic parameters were analyzed in a Cox proportional hazards model for 36 patients with surgically resected pancreatic adenocarcinoma. Abbreviations: HR hazard ratio, CI confidence interval, y years, R1 resection denotes a microscopically positive margin; Positive lymph node ratio refers to the number of lymph nodes positive for malignancy divided by the total number of lymph nodes examined; cm centimeters. *, P < .05